BEHAVIORAL AND NEUROCHEMICAL EVIDENCE FOR AN INTERACTION OF CCK WITH D1-DOPAMINE RECEPTORS

Similar Items

• Chronic neuroleptic-induced mouth movements in the rat: suppression by CCK and selective dopamine D1 and D2 receptor antagonists.
  by: Stoessl, A, et al.
  Published: (1989)
• REVERSAL OF CCK-INDUCED HYPOLOCOMOTION IN THE MOUSE BY THE CCK-A ANTAGONIST DEVAZEPIDE BUT NOT BY THE CCK-B ANTAGONIST L-365,260
  by: Oneill, M, et al.
  Published: (1990)
• MORPHINE ANALGESIA IN THE RAT PAW PRESSURE TEST IS BLOCKED BY CCK BUT POTENTIATED BY THE CCK ANTAGONIST MK-329
  by: Oneill, M, et al.
  Published: (1988)
• EVIDENCE THAT THE ANXIOLYTIC-LIKE EFFECTS OF THE CCK ANTAGONISTS DEVAZEPIDE AND L-365,260 IN THE ELEVATED PLUS-MAZE PARADIGM IN RATS ARE MEDIATED BY CCK RECEPTORS
  by: Ravard, S, et al.
  Published: (1990)
• The selective CCK-B receptor antagonist L-365,260 enhances morphine analgesia and prevents morphine tolerance in the rat.
  by: Dourish, C, et al.
  Published: (1990)